GlassScriptPhysician profile
Roy David Swanson
NPI 1952807810
$3,465.70
in general payments reported to CMS, 2019-2025
14 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $124 · 2021: $165 · 2022: $471 · 2023: $1,413 · 2024: $823 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,705.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,293.70 | 2020-2025 | Hydrus Microstent, Clareon, Centurion |
| Rxsight INC | $712.55 | 2022-2023 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal) |
| Glaukos Corporation | $591.26 | 2022-2025 | Istent Infinite Trabecular Micro-Bypass System Model Is3, Istent Infinite, Idosetr |
| Johnson & Johnson Surgical Vision, INC. | $243.89 | 2023-2025 | Tecnis Simplicity, Tecnis Iol, Veritas Vision System |
| Carl Zeiss Meditec USA, INC. | $145.00 | 2024 | Humphrey Hfa |
| Ivantis, INC | $121.26 | 2021 | |
| Genentech USA, INC. | $115.41 | 2023 | Vabysmo |
| Allergan, INC. | $110.96 | 2020 | |
| Abbvie INC. | $27.75 | 2024 | |
| Horizon Therapeutics Plc | $24.05 | 2021 | |
| Bausch & Lomb Americas INC. | $20.42 | 2025 | Stellaris, Envista Mx60 Iol |
| Oyster Point Pharma, INC. | $19.96 | 2024 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $19.93 | 2021 | |
| Carl Zeiss Meditec Cataract Technology INC. | $19.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Swanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.